HomeHIV/Aids
HIV/Aids
Pepfar chief pushes for extension of programme
USAids relief programme head John Nkengasong is committed to persuading Congress to return to granting a five-year reauthorisation of the programme, he said in...
Gilead inks deal for generic HIV drug supply to low-income nations
Gilead Sciences has granted royalty-free licences to six generic drug manufacturers to make and sell cheaper copycat versions of its HIV prevention medicine in...
African drug makers urged to adopt a regional approach
US global Aids co-ordinator John Nkengasong has called on African pharmaceutical companies to investigate the possibility of a regional manufacturing approach, to take advantage of...
Western Cape youngsters drive province's HIV spike
Findings of an extensive survey released by the Human Sciences Research Council last week include that sexual debut before the age of 15 –...
Survey shows HIV rates soaring in Mpumalanga
Nearly 900 000 people in Mpumalanga (or 17.4% of the population) are HIV positive, giving it the dubious title of province with the highest infection in the country, according...
US to buy African-made ARVs for Pepfar programme
America is throwing its weight behind African production of antiretrovirals, with the US President’s Emergency Plan for Aids Relief programme (Pepfar) committing to buying...
HIV drug trial success triumph for Professor Bekker
In a fitting acknowledgement last week at the International Aids Conference in Munich, Germany, Cape Town’s Professor Linda-Gail Bekker received a standing ovation when...